Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New drug combo may speed blood recovery after cancer transplant

NCT ID NCT07362810

First seen Jan 26, 2026 · Last updated May 01, 2026 · Updated 14 times

Summary

This study tests whether adding a drug called IL-11 to the standard G-CSF can help blood cells recover faster after a stem cell transplant in people with blood cancers like multiple myeloma or lymphoma. The goal is to shorten the time for platelets and red blood cells to return to normal levels, reducing the need for transfusions. About 224 adults will take part in this phase 2 trial across multiple centers in China.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEMATOPOETIC STEM CELL TRANSPLANTATION are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Huadong Hospital, Fudan University

    RECRUITING

    Shanghai, Shanghai Municipality, 200040, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • The first affiliated hospital of Zhengzhou university

    RECRUITING

    Zhengzhou, Henan, 450052, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Tongji Hospital of Tongji University

    RECRUITING

    Shanghai, Shanghai Municipality, 200065, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.